{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:06:22Z","timestamp":1770447982283,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European Commission FP7"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12020-016-1097-0","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T03:52:00Z","timestamp":1473825120000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial"],"prefix":"10.1007","volume":"57","author":[{"name":"for the EUROCONDOR trial investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Trento","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Durando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Lavecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Charrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angelo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Sim\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"key":"1097_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ophtha.2009.09.035","volume":"117","author":"EL Lamoureux","year":"2010","unstructured":"E.L. Lamoureux, E.S. Tai, J. Thumboo et al., Impact of diabetic retinopathy on vision-specific function. Ophthalmology 117, 757\u2013765 (2010)","journal-title":"Ophthalmology."},{"key":"1097_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/bjo.2010.191312","volume":"95","author":"EK Fenwick","year":"2011","unstructured":"E.K. Fenwick, K. Pesudovs, G. Rees et al., The impact of diabetic retinopathy: understanding the patient\u2019s perspective. Br. J. Ophthalmol. 95, 774\u2013782 (2011)","journal-title":"Br. J.Ophthalmol."},{"key":"1097_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11136-008-9327-4","volume":"17","author":"M Finger","year":"2008","unstructured":"M. Finger, G. Fleckenstein, F. Holz et al., Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools. Qual. Life Res. 17, 559\u2013574 (2008)","journal-title":"Qual. Life Res."},{"key":"1097_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1444-0938.2012.00745.x","volume":"95","author":"G Rees","year":"2012","unstructured":"G. Rees, M.B. Sasongko, E.K. Fenwick et al., Impact of diabetic retinopathy on patients\u2019 beliefs about diabetes. Clin. Exp. Optom. 95, 371\u2013376 (2012)","journal-title":"Clin. Exp.Optom."},{"key":"1097_CR5","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1136\/bjophthalmol-2012-302005","volume":"96","author":"R Sim\u00f3","year":"2012","unstructured":"R. Sim\u00f3, C. Hern\u00e1ndez, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br. J. Ophthalmol. 96, 1285\u20131290 (2012)","journal-title":"Br. J. Ophthalmol."},{"key":"1097_CR6","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.2337\/db13-1628","volume":"63","author":"KJ Hellgren","year":"2014","unstructured":"K.J. Hellgren, E. Agardh, B. Bengtsson, Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study. Diabetes 63, 3104\u20133111 (2014)","journal-title":"Diabetes"},{"key":"1097_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12020-014-0232-z","volume":"46","author":"C Hern\u00e1ndez","year":"2014","unstructured":"C. Hern\u00e1ndez, O. Sim\u00f3-Servat, R. Sim\u00f3, Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives. Endocrine 46, 209\u2013214 (2014)","journal-title":"Endocrine"},{"key":"1097_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000444396","volume":"56","author":"U Frydkjaer-Olsen","year":"2016","unstructured":"U. Frydkjaer-Olsen, R. Soegaard Hansen, R. Sim\u00f3 et al., Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Ophth. Res. 56, 10\u201316 (2016)","journal-title":"Ophth. Res."},{"key":"1097_CR9","first-page":"174","volume":"36","author":"SS Feman","year":"1995","unstructured":"S.S. Feman, T.C. Leonard-Martin, J.S. Andrews et al., A quantitative system to evaluate diabetic retinopathy from fundus photographs. Invest. Ophthalmol. Vis. Sci. 36, 174\u2013181 (1995)","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1097_CR10","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"C.M. Mangione, P.P. Lee, P.R. Gutierrez et al., National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item national eye institute visual function questionnaire. Arch. Ophthalmol. 119, 1050\u20131058 (2001)","journal-title":"Arch.Ophthalmol."},{"key":"1097_CR11","first-page":"606","volume":"42","author":"AT Broman","year":"2001","unstructured":"A.T. Broman, B. Munoz, S.K. West et al., Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: proyecto VER. Invest. Ophthalmol. Vis. Sci. 42, 606\u2013613 (2001)","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1097_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00061198-200306000-00006","volume":"12","author":"GC Rossi","year":"2003","unstructured":"G.C. Rossi, G. Milano, C. Tinelli, The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity and reliability. J. Glaucoma. 12, 213\u2013220 (2003)","journal-title":"J. Glaucoma."},{"key":"1097_CR13","first-page":"39","volume":"4","author":"GH Franke","year":"2002","unstructured":"G.H. Franke, J. Esser, J. Reimer, N. Maehner, Vision targeted QoL under different degrees of visual impairment. R. Portug. Psicos. 4, 39\u201349 (2002)","journal-title":"R. Portug. Psicos"},{"key":"1097_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2165\/00019053-200422030-00005","volume":"22","author":"JP Nordmann","year":"2004","unstructured":"J.P. Nordmann, M. Viala, K. Sullivan, B. Arnould, G. Berdeaux, Psychometric Validation of the National Eye Institute Visual Function Questionnaire\u201325 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics 22, 197\u2013206 (2004)","journal-title":"Pharmacoeconomics"},{"key":"1097_CR15","first-page":"A4290","volume":"58","author":"MS Soresen","year":"2011","unstructured":"M.S. Soresen, S. Andersen, G.O. Henningsen, T.L. S\u00f8rensen, Danish version of Visual Function Questionnaire-25 and its use in age-related macular degeneration. Danish medical bulletin 58, A4290 (2011)","journal-title":"Danish medical bulletin"},{"key":"1097_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00417-009-1186-3","volume":"248","author":"C Hirneiss","year":"2010","unstructured":"C. Hirneiss, C. Schmid-Tannwald, M. Kernt, A. Kampik, A.S. Neubauer, The NEI VFQ-25 vision-related quality of life and prevalence of eye disease in a working population. Graefes Arch. Clin. Exp. Ophthalmol. 248, 85\u201392 (2010)","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"1097_CR17","doi-asserted-by":"publisher","first-page":"e005498","DOI":"10.1136\/bmjopen-2014-005498","volume":"4","author":"AE Hipwell","year":"2014","unstructured":"A.E. Hipwell, J. Sturt, A. Lindenmeyer, I. Stratton, R. Gadsby, P. O\u2019Hare, P.H. Scanlon, Attitudes, access and anguish: a qualitative interview study of staff and patients\u2019 experiences of diabetic retinopathy screening. BMJ Open 4, e005498 (2014)","journal-title":"BMJ Open"},{"key":"1097_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10633-014-9476-4","volume":"130","author":"BE Wolff","year":"2015","unstructured":"B.E. Wolff, M.A. Bearse Jr, M.E. Schneck et al., Color vision and neuroretinal function in diabetes. Doc. Ophthalmol. 130, 131\u2013139 (2015)","journal-title":"Doc. Ophthalmol."},{"key":"1097_CR19","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00592-015-0806-0","volume":"52","author":"M Trento","year":"2015","unstructured":"M. Trento, L. Charrier, M. Salassa et al., Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study. Acta Diabetol. 52, 1157\u20131166 (2015)","journal-title":"Acta Diabetol."},{"key":"1097_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00592-013-0470-1","volume":"50","author":"M Trento","year":"2013","unstructured":"M. Trento, P. Passera, M. Trevisan et al., Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study. Acta Diabetol. 50, 873\u2013877 (2013)","journal-title":"Acta Diabetol."},{"key":"1097_CR21","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1136\/bjo.85.12.1484","volume":"85","author":"L Dandona","year":"2001","unstructured":"L. Dandona, Dandona. Socioeconomic status and blindness. Br. J.Ophthalmol. 85, 1484\u20131488 (2001)","journal-title":"Br. J.Ophthalmol."},{"key":"1097_CR22","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(05)74234-3","volume":"365","author":"M Marmot","year":"2005","unstructured":"M. Marmot, Social determinants of health inequalities. Lancet 365, 1099\u20131104 (2005)","journal-title":"Lancet"},{"key":"1097_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1442-9071.2011.02697.x","volume":"40","author":"EL Lamoureux","year":"2012","unstructured":"E.L. Lamoureux, E. Fenwick, J. Xie et al., Methodology and early findings of the Diabetes Management Project: a cohort study investigating the barriers to optimal diabetes care in diabetic patients with and without diabetic retinopathy. Clin. Experiment.Ophthalmol. 40, 73\u201382 (2012)","journal-title":"Clin. Experiment.Ophthalmol."},{"key":"1097_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/bjophthalmol-2013-304017","volume":"99","author":"RL Thomas","year":"2015","unstructured":"R.L. Thomas, F.D. Dunstan, S.D. Luzio et al., Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br. J. Ophthalmol. 99, 64\u201368 (2015)","journal-title":"Br. J. Ophthalmol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1097-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1097-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1097-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T13:39:46Z","timestamp":1567777186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1097-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1097"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1097-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,14]]},"assertion":[{"value":"8 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"F. Bandello and R. Lattanzio (Scientific Institute San Raffaele, Italy), J. Cunha-Vaz and M.A. Costa (Association for Innovation and Biomedical Research on Light and Image, Portugal), C. Egan (Moorfields Eye Hospital, UK), J. Garc\u00eda-Arum\u00ed (Valld\u2019Hebron University Hospital, Spain), J. Gibson (University of Aston, UK), S. Harding (University of Liverpool, UK), S. Karadeniz (International Diabetes Federation, Europe Region, IDF Europe), G. Lang (University of Ulm, Germany), P. Massin (H\u00f4pitalLariboisi\u00e8re-APHP, France), E. Midena (University of Padova, Italy), B. Ponsati (BCN Peptides, Spain), M. Porta (University of Turin, Italy), P. H. Scanlon and S. J. Aldington (Cheltenham General Hospital, UK), R. Sim\u00f3 and C. Hern\u00e1ndez (Valld\u2019Hebron Research Institute and CIBERDEM, Spain), J. Grauslund (Odense University Hospital, Denmark).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Members of EUROCONDOR, who have contributed to this paper"}}]}}